Recipient of federal assistance · CAMBRIDGE, MA

NOVOBIOTIC PHARMACEUTICALS, LLC

NOVOBIOTIC PHARMACEUTICALS, LLC received $0 in federal grants and other assistance in FY2026, on 3 actions, −100% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $17.5M.

Assistance · FY2026
$0
New awards
0
Actions
3
Since FY2021
$17.5M
UEI
GUV4CZLZE5Z2
Location
CAMBRIDGE, MA
BusinessesOther recipients
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 3.7MFY2021
  2. 3.2MFY2022
  3. 6.9MFY2023
  4. 2.5MFY2024
  5. 1.1MFY2025
  6. 0FY2026

Top programs · Awarding agencies

Obligations in FY2026.

Largest awards

  1. DEVELOPING TEIXOBACTIN FOR RESPIRATORY INFECTIONS - ABSTRACT: THE MAJOR GOAL OF THIS PROPOSAL IS TO INVESTIGATE THE POTENTIAL FOR…$6.2M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Mar 26, 2021 – Dec 1, 2025· R01AI159444
  2. LATE-STAGE PRECLINICAL DEVELOPMENT OF TEIXOBACTIN TO TREAT DRUG-RESISTANT INFECTIONS$4.5M
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· Apr 20, 2023 – Apr 16, 2026· HT94252310376
  3. TEIXOBACTIN DEVELOPMENT FOR TUBERCULOSIS - ABSTRACT THE GOAL OF THIS PROPOSAL IS TO INVESTIGATE THE POTENTIAL FOR TEIXOBACTIN (TXB) TO…$3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 29, 2022 – Feb 13, 2026· R44AI172478

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.